Similar articles

• Growth factor receptors: implications in tumor biology.

  Srinivasan DM, Kapoor M, Kojima F, Crofford LJ. Srinivasan DM, et al. Curr Opin Investig Drugs. 2005 Dec;6(12):1246-9. Curr Opin Investig Drugs. 2005. PMID: 16370390 Review.
• Inhibitors of growth factor receptor kinase-dependent signaling pathways in anticancer chemotherapy--clinical progress.

  Renhowe PA. Renhowe PA. Curr Opin Drug Discov Devel. 2002 Mar;5(2):214-24. Curr Opin Drug Discov Devel. 2002. PMID: 11926128 Review.
• Molecular mechanisms of signal transduction: epidermal growth factor receptor family, vascular endothelial growth factor family, Kit, platelet-derived growth factor receptor, Ras.

  Erman M. Erman M. J BUON. 2007 Sep;12 Suppl 1:S83-94. J BUON. 2007. PMID: 17935283 Review.
• Inhibitors of growth factor receptors, signaling pathways and angiogenesis as therapeutic molecular agents.

  Holash J, Thurston G, Rudge JS, Yancopoulos GD, Adjei AA, Bergers G, Pytowski B, Pegram M, Gordon MS. Holash J, et al. Cancer Metastasis Rev. 2006 Jun;25(2):243-52. doi: 10.1007/s10555-006-8504-6. Cancer Metastasis Rev. 2006. PMID: 16770536 Review. No abstract available.
• Key cancer cell signal transduction pathways as therapeutic targets.

  Bianco R, Melisi D, Ciardiello F, Tortora G. Bianco R, et al. Eur J Cancer. 2006 Feb;42(3):290-4. doi: 10.1016/j.ejca.2005.07.034. Epub 2006 Jan 11. Eur J Cancer. 2006. PMID: 16376541 Review.